Back
Celularity, Inc. 10K Form
Sell
9
CELU
Celularity, Inc.
Last Price:
$1.45
Seasonality Move:
-11.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-08-19 | 10Q | CELU/Celularity, Inc. Quarterly |
| 2020-08-13 | 10Q | CELU/Celularity, Inc. Quarterly |
| 2019-11-13 | 10Q | CELU/Celularity, Inc. Quarterly |
Receive CELU News And Ratings
See the #1 stock for the next 7 days that we like better than CELU
CELU Financial Statistics
Sales & Book Value
| Annual Sales: | $54.2M |
|---|---|
| Cash Flow: | $-4.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.71 |
| Price / Book: | 10.68 |
Profitability
| EPS (TTM): | -3.33100 |
|---|---|
| Net Income (TTM): | $-80.6M |
| Gross Margin: | $31.3M |
| Return on Equity: | -1606.74% |
| Return on Assets: | -50.01% |
Celularity, Inc. Earnings Forecast
Key Celularity, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for CELU is 57.74%.
-
The Selling, General & Administrative Expenses for CELU have been equal to 108.16% of Gross Profit Margin.
-
The Research & Development expenses have been 20.69% of Revenue.
-
The Net Earning history of CELU is -106.77% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 3 years.
Celularity, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CELU |
| Website: | celularity.com |
Debt
| Debt-to-Equity Ratio: | -3.32 |
|---|---|
| Current Ratio: | 0.16 |
| Quick Ratio: | 0.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CELU Technical Analysis vs Fundamental Analysis
Sell
9
Celularity, Inc. (CELU)
is a Sell
Is Celularity, Inc. a Buy or a Sell?
-
Celularity, Inc. stock is rated a SellThe current Celularity, Inc. [CELU] share price is $1.45. The Score for CELU is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.